The Global Amniotic Membrane Market Size accounted for USD 3.1 Billion in 2021 and is projected to achieve a market size of USD 10.2 Billion by 2030 rising at a CAGR of 14.2% from 2022 to 2030. Increasing awareness among the people in the recent past has led to a surge in the number of transplants leading to rising demand for these tissue-based products. It has also led to increase in the number of donations thus, boosting market growth.

Amniotic Membrane Market Report Statistics

• Global amniotic membrane market revenue is estimated to reach USD 10.2 Billion by 2030 with a CAGR of 14.2% from 2022 to 2030
• North America amniotic membrane market share accounted for over 32% shares in 2021
• According to the Plastic Surgery Statistics Report 2020, there were 15.6 million cosmetic procedures performed
• Asia-Pacific amniotic membrane market growth will register swift CAGR from 2022 to 2030
• Based on enzyme, cryopreserved amniotic membrane acquired over 59% of the overall market share in 2021
• Among end-use, hospitals acquired over 40% market chunk in 2021
• Increasing demand for amniotic membrane in ophthalmic surgeries will fuel the global amniotic membrane market value
• Rising usage for amniotic eye treatment is a popular amniotic membrane market trend that is fueling the industry demand

Amniotic membrane has piqued the interest of healthcare providers and doctors due to its numerous benefits, including restoring epidermal function and integrating itself into the healing process, as well as acting as a skin substitute in wound care. Depending on the indication, amniotic membrane is used as a graft or patch in the treatment of eye diseases. Because of the disruptions in the supply chain caused by the COVID-19 outbreak, the market suffered. The market was hampered by a temporary halt in supply and manufacturing, which limited revenue generation. However, key players are launching a variety of initiatives to address the challenges faced by the COVID-19 lockdown.

Global Amniotic Membrane Market Dynamics

Market Drivers

• Growing in the target patient population
• Growth in the number of accident and trauma wounds
• Rising awareness towards benefits offered by amniotic membrane

Market Restraints

• Lack of standardized guidelines
• Shortage of skilled professionals

Market Opportunities

• Surging venture capital investments and government spending
• Increasing research on stem cell biology

Amniotic Membrane Market Report Coverage

Market	Amniotic Membrane Market
Amniotic Membrane Market Size 2021	USD 3.1 Billion
Amniotic Membrane Market Forecast 2030	USD 10.2 Billion
Amniotic Membrane Market CAGR During 2022 - 2030	14.2%
Amniotic Membrane Market Analysis Period	2018 - 2030
Amniotic Membrane Market Base Year	2021
Amniotic Membrane Market Forecast Data	2022 - 2030
Segments Covered	By Enzyme, By Application, By End-Use, And By Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	Amnio Technology, Alliqua BioMedical Inc., Applied Biologics LLC, Human Regenerative Technologies, Amniox Medical Inc., DermaSciences, Organogensis, Inc., Katena Products, Inc., Skye Biologics, Inc., and MiMedx Group Inc.
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Amniotic Membrane Market Growth Factors

Increasing hazardous cases in trauma, burnt cases and leading to cure through surgeries, also increasing awareness highlighting the benefits of amniotic membrane based products are boosting the demand for the products driving the global amniotic membrane market. Increasing cases of cosmetic surgeries performed worldwide is also another factor likely to drive the growth of market during the forecast period. Amniotic membrane is also being utilized in the healing of a large number of ocular surface diseases as it protects surfaces from microbial colonization minimizing the risk of infections.

Amniotic Membrane Market Insights

Numerous NGOs such as American Association of Tissue Banks which regulates tissue donation in the U.S. Presence of similar tissue banks is to ensure zero infection transmission which leads to diseases, which, sequentially, accelerates market growth by increasing the demand. Moreover, a number of medical institutions are trying to bring in novel areas of application for these products by focusing on the research activities in regenerative medicines and applications of stem cell. This is among the other prime factors that are likely to maintain market expansion globally. Cryopreserved amniotic membrane is widely used in hospitals, ambulatory surgical centers (ASCs), and few other specialty clinics. Lyophilization of the tissue post donation conserve the biological and histological activity of the tissue facilitating faster wound recovery.

Amniotic Membrane Market Segmentation

The global amniotic membrane market is segmented based on enzyme, application, end-use, and geography.

Amniotic Membrane Market By Enzyme

• Cryopreserved Amniotic Membrane
• Dehydrated Amniotic Membrane

According to our amniotic membrane industry analysis, the cryopreserved amniotic membrane section was the significant revenue contributor in 2021 and is expected to continue this trend during the forecast period. The high share in the segment was credited to its high efficiency and adoption rates globally. This type of membrane is typically stored at -80°C in a cell culture medium containing 50% glycerol. The histological and biological properties of the amniotic membrane are well preserved in cryopreserved amniotic membranes.

Amniotic Membrane Market By Application

• Surgical Wounds
• Ophthalmology
• Others

According to our analysis, surgical wounds generated the largest revenue in 2021 and are expected to continue its trend during the forecast timeframe from 2022 to 2030. Because of the increasing prevalence of chronic and infectious diseases, there has been a global increase in the number of surgeries, boosting market potential.

Amniotic Membrane Market By End-Use

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)
• Research and Academic Institutes

According to our amniotic membrane market forecast, hospital segment would gain significant impetus from 2022 to 2030. This is mainly due to frequent visits by patients as hospitals are the primary care settings facilitating easy treatment for a wide range of diseases. The increasing use of amniotic membranes in ASCs is anticipated to be another significant factor driving market growth in the coming years.

Amniotic Membrane Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Amniotic Membrane Market Regional Analysis

Among the regions, North America amniotic membrane market is a leading having the maximum share owing to presence of a large number of key companies and high incidence of infectious and chronic diseases. This region is expected to continue having the maximum market share during the forecast period. The Asia-Pacific amniotic membrane market is anticipated to record the highest CAGR during the forecast period owing to growing population and rising incidence of burn injuries and chronic diseases.

Amniotic Membrane Market Players

The key players catering to the global amniotic membrane market are Amnio Technology, Alliqua BioMedical Inc., Applied Biologics LLC, Human Regenerative Technologies, Amniox Medical Inc., DermaSciences, Organogensis, Inc., Katena Products, Inc., Skye Biologics, Inc., and MiMedx Group Inc. The global players are continuously investing in R&D activities and innovating to have updated product portfolio to attract more and more business opportunity from the emerging nation such as India and China. Further changing customers’ preferences are encouraging global players to develop innovative technology solution to cater best to the market. Also, Increasing R&D investments coupled with technological advancements to commercialize highly efficient products are anticipated to offer lucrative opportunities for industry participants.

TABLE OF CONTENT